Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Wisee who wrote (705)	5/14/1998 4:55:00 PM
From: Edward W. Richmond	Respond to of 1185

Wisee, it was good to meet the Prairie folk at Nortran's AGM. I was impressed with the drug pipeline that Nortran is developing. It is reassuring to have several potentially successful products and to see the company attracting quality partners. I particularly like the Nortran's current financial position which, prior to financing, has 2 years of funding at our current burn rate. With our present management,products and financing, I expect to do well with NRT stock. I doubled my position at $2.05. If the stock drops, I'll buy again. Regards, Ed P.S. Sorry about those Oilers.